Evaluated by: David B. Kaminsky, M.D., FIAC, March 21, 2018
Original release date: May 29, 2018
Access to this course expires on: March 21, 2021
Faculty: Stuart Schnitt, M.D.
- Identify which biomarkers and/or molecular tests to perform on all breast core needle biopsies with a new diagnosis of invasive breast cancer
- Describe the management of patients with lobular carcinoma in situ (LCIS) detected on breast core needle biopsy
- Recognize the epithelioid variant of mammary-type myofibroblastoma